Nifedipine
54 ; Title of the invention : "HEPARIN-DERIVED POLYSACCHARIDE MIXTURES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME" 51 ; International classification : C08E 37 10 71 ; Name of Applicant : 31 ; Priority Document No : 00 09572 1 ; AVENTIS PHARMA S.A. 32 ; Priority Date : 21 07 2000 Address of Applicant : 20, AVENUE RAYMOND-ARON, F 33 ; Name of priority country : France 92160 ANTONY, FRANCE. France 86 ; International Application No : PCT FR01 02332 72 ; Name of Inventor : Filing Date : 18 07 2001 ; JACQUES DIAZ 87 ; International Publication No : WO 08295 2 ; CHRISTELLE PECQUET 61 ; Patent of Addition to Application Number : NA 3 ; ELISABETH PERRIN Filing Date : NA 4 ; CHRISTIAN VISKOV 62 ; Divisional to to Application Number : NA Filing Date : NA 57 ; Abstract : The invention concerns heparin-derived polysaccharide mixtures, their preparation method and pharmaceutical compositions containing them.
Nifedipine ointment 2Procardia is contraindicated in patients with a known hypersensitivity reaction to nifedipine. Louis R. Bucalo, M.D. is the founder of Titan and has served as our President and Chief Executive Officer since January 1993. Dr. Bucalo has served as a director of Titan since March 1993 and was elected Chairman of the Board of Directors in January 2000. From July 1990 to April 1992, Dr. Bucalo was Associate Director of Clinical Research at Genentech, Inc., a biotechnology company. Dr. Bucalo holds an M.D. from Stanford University and a B.A. in biochemistry from Harvard University. Sunil Bhonsle has served as our Executive Vice President and Chief Operating Officer since September 1995, and has served as a director of Titan since February 2004. Mr. Bhonsle served in various positions, including Vice President and General Manager-Plasma Supply and Manager-Inventory and Technical Planning, at Bayer Corporation from July 1975 until April 1995. Mr. Bhonsle holds an M.B.A. from the University of California at Berkeley and a B.Tech. in chemical engineering from the Indian Institute of Technology. Richard C. Allen, Ph.D., has served as our Executive Vice President, Cell Therapy, since August 1995. From January 1995 until it was merged into Titan in March 1999, he also served as President and Chief Executive Officer of Theracell, Inc. From June 1991 until December 1994, Dr. Allen was Vice President and General Manager of the Neuroscience Strategic Business Unit of Hoechst-Roussel Pharmaceuticals, Inc. Dr. Allen holds a Ph.D. in medicinal chemistry and a B.S. in pharmacy from the Medical College of Virginia. Robert E. Farrell has served as our Executive Vice President and Chief Financial Officer since September 1996. Mr. Farrell was employed by Fresenius USA, Inc. from 1991 until August 1996 where he served in various capacities, including Vice President Administration, Chief Financial Officer and General Counsel. His last position was Corporate Group Vice President. Mr. Farrell holds a B.A. from the University of Notre Dame and a J.D. from Hastings College of Law, University of California.
Patients in the angina prognosis study in stockholm APSIS ; . J Intern Med 1997; 241 1 ; : 59-69. Henry JA, Chester PC and Latham AN. Sustained-release verapamil or atenolol in essential hypertension. Journal of Drug Development 1988; 1 2 ; : 69-75. Henry M, Wehrlen M, Pelletier B, et al. Spironolactone versus nifedipine in essential hypertension. J Cardiol 1990; 65 23 ; : 36K-38K. Heper G and Bayraktaroglu M. The importance of von Willebrand factor level and heart rate changes in Acute Coronary Syndromes: A comparison with chronic ischemic conditions. Angiology 2003; 54 3 ; : 287-299. Hergueta Garcia de Guadiana G and Paumard Fraguas A. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension]. An Med Interna 1989; 6 1 ; : 15-8. Hernandez RH, Armas-Hernandez MJ, Chourio JAC, et al. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses. Blood Press Monitor 2001; 6 1 ; : 47-57. Hernandez-Hernandez R, Armas-Padilla MC, Velasco M, et al. Effects of amlodipine and enalapril on platelet function in patiens with mild to moderate hypertension. Int J Clin Pharmacol Ther 1999; 37 7 ; : 323-331. Herpin D, Brion N and Debregeas B. Comparison of the antihypertensive effects of sustained-release diltiazem 240 and 300 mg in patients with mild to moderate hypertension with analysis of ambulatory blood pressure profiles. Curr Ther Res Clin Exp 1990; 47 2 ; : 328-338.
March-April 1999 Bartenders show small but definite improvements in respiratory function and health after the California ban on smoking in bars and taverns. In addition to these improvements--including a 4.2% increase in FVC and a 1.2% increase in FEV1--smoking bans at work have the potential to reduce long-term risk of lung cancer and cardiovascular disease. COMMENT: This article is of importance to allergists because of the well-accepted connection between smoke exposure and allergic disease asthma. This is an interesting study looking at the improvement in respiratory disease symptoms and spirometry although the changes are small ; in bartenders after their work environment becomes smoke-free. Ron Davis' editorial is a nice review on ETS, and there is even a patient education page that physicians can copy for their patients. S. R. W. Eisner MD, Smith AK, Blanc PD: Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA 280: 1909-1914, 1998 and aripiprazole.
Table 3. Adverse Reactions Reported in at Least 10% of Patients with MRCC Who Received SUTENT or IFN- * Treatment-Nave MRCC Adverse Reaction, n % ; SUTENT n 375 ; IFN- n 360 ; All Grades Grade 3 4a All Grades Grade 3 4b 370 ; 250 67 ; 354 98 ; 184 51 ; Any Constitutional Fatigue 218 58 ; 35 9 ; 199 55 ; 50 14 ; Asthenia 79 21 ; 27 Fever 62 17 ; 3 129 36 ; 0 0 ; Weight decreased 45 12 ; 0 Chills 42 11 ; 3 108 30 ; 0 0 ; Gastrointestinal Diarrhea 0 0 ; 218 58 ; 22 6 ; Nausea 5 1 ; 183 49 ; 16 4 ; 136 38 ; 2 1 ; Mucositis stomatitis 14 4 ; 162 43 ; 12 3 ; Vomiting 51 14 ; 105 28 ; 15 4 ; Dyspepsia 14 4 ; 105 28 ; 4 1 ; Abdominal painc 1 ; 44 Constipation 1 ; 26 Dry mouth GERD reflux 0 0 ; 3 esophagitis 0 0 ; 8 Flatulence 0 0 ; 2 Oral pain 0 0 ; 2 Glossodynia Cardiac Hypertension 111 30 ; 36 10 ; Edema, peripheral 42 11 ; 2 Dermatology Rash 103 27 ; 3 1 ; Hand-foot syndrome 78 21 ; 20 Skin discoloration yellow skin 72 19 ; 0 Dry skin 67 18 ; 1 Hair color changes 56 16 ; 0 Neurology 166 44 ; 1 ; Altered tasted 68 18 ; 3 Headache 28 7 ; 1 Dizziness Musculoskeletal Back pain 70 19 ; 13 Arthralgia 69 18 ; 5 Pain in extremity limb discomfort 65 17 ; 6 Respiratory Cough 64 18 ; 2 Dyspnea 58 15 ; 15 Metabolism Nutrition Anorexiae 142 38 ; 6 2 ; 145 40 ; 7 2 ; Dehydration 30 8 ; 8 Hemorrhage Bleeding Bleeding, all sites 112 30 ; 27 8 ; Psychiatric Insomnia 42 11 ; 1 Depressiong 29 8 ; 0 Common Terminology Criteria for Adverse Events CTCAE ; , Version 3.0 a Grade 4 ARs in patients on SUTENT included back pain 1% ; , arthralgia 1% ; , asthenia 1% ; , dehydration 1% ; , fatigue 1% ; , limb pain 1% ; and rash 1% ; . b Grade 4 ARs in patients on IFN- included dyspnea 1% ; , fatigue 1% ; and depression 1% ; . c Includes flank pain d Includes ageusia, hypogeusia and dysgeusia e Includes decreased appetite f Includes one patient with Grade 5 gastric hemorrhage g Includes depressed mood Treatment-emergent Grade 3 4 laboratory abnormalities are presented in Table 4, for example, nifedipine effects.
With or without raloxifene, 30-minute incubation ; before cumulative addition of CaCl2. The effects of nifedipine 1 mol L ; were also tested on agonist-induced contractions and quinapril. Study Hilleman et al. 47 Amlodipine benazepril vs. 9 monotherapies lisinopril verapamil captopril HCTZ amlodipine atenolol nifexipine diltiazem enalapril. Neurosci Lett 198, 109-112 1995 ; 18. Holley, L. A. Dudchenko, P. and Sarter, M. Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alteration performance by the triazole MDL26479. Psychopharmacol 109, 223-230 1992 ; 19. Ukai, M. Itoh, J. Kobayashi, T. Shinkai, N. and Kameyama, T. Effects of the kappa-opioid dynorphin A 1-13 ; on learning and memory in mice. Behav Brain Res 83, 169-172 1997 ; 20. Maren, S. and Baudry, M. Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory. Neurobiol Learning Memory 63, 1-18 1992 ; 21. Craig, C. R. and Stitzel, R. E. Modern Pharmacology 5th edn. Little, Brown & Co. Boston 1997 ; 22. Schmage, N. and Bergener, M. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Intl Psychogeriatrics 4 Suppl ; 1, 89-99 1992 ; . 23. Mattson, M. P. Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 27, 29-49 1992 ; 24. Maurice, T. Bayle, J. and Privat, A. Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav Pharmacol 6, 167-175 1995 ; 25. Maurice, T. Su, T. P. Parish, D. W. and Privat, A. Prevention of nimodipine-induced impairment of learning by the selective sigma ligand PRE-084. J. Neural Transm 102, 1-18 1995 ; 26. Nikolaev, E. and Kaczmarek, L. Disruption of two-way acitive avoidance behavior by nimodipine. Pharmcol Biochem Behav 47, 757-759 1994 ; 27. Deyo, R. A. Nix, D. A. and Parker, T. W. Nifdipine blocks retention of a visual discrimination task in chicks. Behav Neural Biol 57, 260-262 1992 ; 28. Lynch, G. Larson, J. Kelso, S. Barrionuevo, G. and Schottler, F. Intracellular injections of EGTA block induction of long-term potentiation. Nature 321, 519-522 1983 ; 29. Malenka, R. C. Kauer, J. A. Zucker, R. S. and Nicoll, R. A. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242, 81-84 1988 ; 30. Shivers, B. D. Hilbich C. Multhaup, G. Salbaum, M. Beyreuther, K. and Seeburg, P. H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 7, 1365-1370 1988 ; 31. Etienne, P. and Baudry, M. Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: a unifying hypothesis. Neurobiol Aging 8, 362-366 1987 ; 32. Konradi, C. Leveque, J-C. and Hyman, S. E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16, 4231-4239. So now if you want to avoid statins and take only alterative medicine, then you have to follow two steps, for example, nifedipine 60 mg. See more webmd videos » arthritis get the latest treatment options webmd privacy policy health extras q& a: ask our health experts a question now » find a therapist » google refined search » visit the raynaud's phenomenon index » top 10 raynaud's phenomenon related articles acetylsalicylic acid antinuclear antibody diltiazem losartan mixed connective tissue disease nifedipine rheumatoid arthritis scleroderma sjogren's syndrome systemic lupus complete list » arthritis topics lupus osteoarthritis gout fibromyalgia rheumatoid arthritis arthritis rss ask the experts daily health news a gentler tonsil surgery exercise and diabetes coli salad risk how sweet is your sweat and reminyl. It is then useful to try: nifedipine. Research cooperation with the Agricultural Research Center Volcani Institute a ; Joint projects aimed at the enhancement of agriculture in arid regions. The following research project were carried out cooperatively by Scientists from China and Israel in both countries: Efficient irrigation and minimization of soil erosion in field crops production in arid regions. Efficient irrigation and minimization of soil erosion in orchards production in arid regions. Intensive cultivation methods for vegetables in arid regions. Breeding of wheat varieties for arid regions. I think i accomplish more than some random healthy person. Presumably responsible for spike generation, disappeared 5 min after the addition of 1 mol l 1 TTX to the bath, leaving only a sustained inward current Fig. 5B ; . Three lines of evidence suggest that this fast transient inward current is a Na current INa ; . First, it was blocked by TTX Fig. 5B second, it was also blocked by Na + -free saline data not shown and third, it was inactivated when the swimmeret motor neurones were held at a potential of 40 mV Connor and Stevens, 1971a ; . The sustained inward current N 35 swimmeret motor neurones ; was not affected by TTX and was increased in amplitude 5 min after equimolar Ba2 + replaced Ca2 + as the charge carrier Fig. 5C ; . It could be blocked 5 min after external application of 2 mmol l 1 Co2 + Fig. 6 ; or Cd2 + not shown ; . Furthermore, this current was significantly reduced in a dose-dependent manner by nifedipine Fig. 7D ; , suggesting that it is an L-type Ca2 + current ICa ; . The effect of nifedipine. Benadryl Extra Strength Nightime diphenhydramine ; Brompheniramine Caladryl calamine, diphenhydramine ; Chlorpheniramine Chlor-Tripolon chlorpheniramine ; Chlor-Tripolon Decongestant chlorpheniramine, pseudoephedrine ; Chlor-Tripolon ND loratidine, pseudoephedrine ; Claritin plain loratadine ; Claritin Allergy and Sinus loratidine, pseudoephedrine ; Coricidin chlorpheniramine, ASA ; Diphenhydramine Dristan, Extra Strength acetaminophen, pheniramine, phenylephrine ; ANTIHYPERTENSIVES Adalat nifedipine ; Altace ramipril ; Apo-Clonidine Apo-Diltiaz Apo-Hydralazine Apo-Methyldopa Apo-Nifed PA nifedipine ; Apo-Verap verapamil ; Apresoline hydralazine ; Atacand candesartan cilexetil ; Avapro irbesartan ; Capoten captopril ; Catapres clonidine ; Chronovera verapamil ; Coversyl perindopril ; Cozaar losartan ; Diovan valsartan ; Hyperstat IV Injection diazoxide ; Inhibace cilazapril ; Isoptin verapamil ; ANTI-INFLAMMATORIES All non-steroidal anti-inflammatories are permitted Apo-Nabumetone Apo-Phenylbutazone Asacol 5-ASA ; Dipentum olsalazine ; Indocid P.D.A. indomethacine. Nifedipine should not be used for the treatment of acute attacks of angina. The safety of nifedipine in malignant hypertension has not been established. Nifedkpine should not be used for secondary prevention of myocardial infarction. Nifedipihe should not be administered concomitantly with rifampicin since effective plasma levels of nifedipine may not be achieved owing to enzyme induction. Caution is required in cases of markedly low blood pressure severe hypotension with less than 90 mm Hg systolic ; as well as in cases of cardiac failure. 4.4 Special warnings and special precautions for use None Interaction with other medicaments and other forms of interaction The hypotensive effect of Nifdeipine can be increased by other hypotensive drugs as well as by tricyclic antidepressants. When combined with nitrates the effects on blood pressure and heart rate increase. When administering Nifedipine and beta-receptor blockers at the same time, careful surveillance of the patient is necessary as this might produce a major lowering of the blood pressure; occasional cardiac failure has also been observed. Adipine MR is not a beta-blocker and therefore gives no protection against the dangers of abrupt beta-blocker withdrawal. Any such withdrawal should be a gradual reduction of the dose of the beta blocker preferably over 8 to 10 days. Adipine MR will not prevent possible rebound effects after cessation of other hypertensive therapy. Certain calcium antagonists may increase the negatively inotropic effect of antiarrhythmics such as amiodarone and quinidine. In this connection, no observations were made with Nifedipine. In individual cases, Nifedipine causes a drop of the quinidine plasma level or after discontinuation of Nifedipine a marked increase of the quinidine plasma level so that in combined therapy the control of the quinidine plasma level is recommended. Nifedipine may cause an increase of theophylline plasma levels so that the control of the latter is recommended. Cimetidine and, to a lesser extent, ranitidine may lead to an increase in the Nifedipine plasma level and thus to a more intensive action of Nifedipine. As with other dihydropyridines, nifedipine should not be taken with grapefruit juice because bioavailability is increased. The simultaneous administration of nifedipine and digoxin may lead to reduced digoxin clearance and hence an increase in the plasma digoxin. Digoxin levels should be monitored and, if necessary, the digoxin dose reduced. Nifedipine should not be administered concomitantly with rifampicin since effective plasma levels of nifedipine may not be achieved owing to enzyme induction see Contraindications ; . 4.6 Pregnancy and Lactation Nifedipine must not be administered during the entire pregnancy as experimental studies have shown foetal deformities. There is no information on humans. Nifedipine penetrates into the mother's milk. As there is no information with respect to possible effects on babies, the child should be weaned, if treatment with Nifedipine should be necessary during the lactation period. Reagents--Clotrimazole, econazole, ketoconazole, nifedipine, and TEA were purchased from Sigma. Charybdotoxin ChTX ; was from Bachem King of Prussia, PA ; . TRAM-34 [1- 2-chlorophenyl ; diphenyl ; methyl]-1H-pyrazole ; , TRAM-3 2-chlorophenyl ; diphenylmethanol ; , and TRAM-39 2- 2-chlorophenyl ; -2, 2-diphenylacetonitrile ; were synthesized as described previously 8 ; . TRAM-30 was prepared by refluxing clotrimazole 2.00 g, 5.81 mmol ; with an excess of methyl iodide in butanone for 36 h. The reaction mixture was evaporated to dryness. On addition of petroleum ether to the resulting oily residue and intensive cooling and scratching, the material began to solidify and was then washed thoroughly with acetone and petroleum ether mp: 139 C; 1H. Nifedipine amlodipine diltiazem felodipine and verapamilRoxicet milligrams, benicar tablets 20mg, tympanometry ppt, how antimicrobial agent work and blastocystis infection what. Benign hard palate lesion, aldara rebate program, pervasive developmental disorder barbara quinn and symptoms exhaustion heat illnesses or meperidine prometh cap. Adalat xl 30mg nifedipineNifedipine ointment 2, effects of nifedipine in pregnancy, nimodipine nifedipine, nifedipine 30mg cr and nifedipine ointment 0.2. Nifedipine amlodipine diltiazem felodipine and verapamil, adalat xl 30mg nifedipine, nifedipine cream recipe and nifedipine compounded or nifedipine capsules 5 mg. © 2009 |